TMDI NASDAQ
Titan Medical Inc.
1W: -31.7%
1M: -83.9%
3M: -76.8%
1Y: -72.5%
3Y: -45.1%
$0.14
Last traded 2023-03-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$20M
+0.5% ▲
Gross Profit
$20M
+0.5% ▲
Operating Income
-$15M
+36.4% ▲
Net Income
-$15M
+41.2% ▲
EPS (Diluted)
$-0.22
+42.1% ▲
EBITDA
-$14M
+38.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $20M | $20M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.5% |
| Cost of Revenue | $0 | $0 | $58K | $0 | $0 |
| Gross Profit | $0 | $0 | -$58K | $20M | $20M |
| Gross Margin | — | — | — | 100.0% | 100.0% |
| R&D Expenses | $13M | $33M | $51M | $8M | $38M |
| SG&A Expenses | $6M | $7M | $8M | $8M | $12M |
| Operating Expenses | $19M | $40M | $59M | $16M | $51M |
| Operating Income | -$34M | -$23M | -$41M | -$23M | -$15M |
| Operating Margin | — | — | — | -115.5% | -73.0% |
| Interest Expense | $0 | $0 | $423K | $1M | $125K |
| Income Before Tax | -$34M | -$23M | -$42M | -$24M | -$15M |
| Tax Expense | $0 | $0 | $423K | $1M | $56K |
| Net Income | -$34M | -$23M | -$42M | -$25M | -$15M |
| Net Margin | — | — | — | -126.4% | -73.9% |
| EPS (Diluted) | $-4.25 | $-1.36 | $-1.38 | $-0.38 | $-0.22 |
| EBITDA | -$34M | -$23M | -$41M | -$23M | -$14M |
| Shares Outstanding | 8M | 17M | 31M | 67M | 67M |